The development of caries and its consequences are causing almost 9 billion euros in health insurance costs for German public health insurers, despite years of declining patient numbers (source: GBA 2017/2015). Therefore, education and screening for caries risks are an integral part of the medical care, already starting for infants, and ideally in close cooperation between pediatricians and pediatric dentists.
The KariesScreenTest, developed by Dr. med. dent. Laurisch, is a caries risk test based on the microbiological, highly selective detection of the caries-causing bacteria Streptococcus mutans and Lactobacillus species from plaque or saliva. Until 2018, it had been available via IvoclarVivadent under the name CRT®.
The successor product is now available under the name KariesScreenTest. It is made by AUROSAN in Germany.
KariesScreenTest is now available in different formats:
- (a) KariesScreenTest (MD2426) with 10 tests.
- (b) KariesScreenTest + P (MD2427) with 5 tests and 5 Salivatests, measuring its buffering capacity
- (c) Salivatest (MD2429 with 10 saliva buffering test kits.
In addition, paraffine pellets are available, separately.
Both KariesScreenTests formats are accompanied by detailed instructions for use, which not only refer to the purchased product, but explain all measures necessary to determine subclinical risk parameters of caries.
KariesScreenTests and Salivatests are available in the countries oft he European Community, as well as in many other countries via the local distributors of AUROSAN`s. If yourselves, you are interested in a distributorship for AUROSAN products, please don’t hesitate to contact us. We look forward to hearing from you.